Search by Drug Name or NDC

    NDC 68462-0879-05 Bisoprolol Fumarate and Hydrochlorothiazide 5; 6.25 mg/1; mg/1 Details

    Bisoprolol Fumarate and Hydrochlorothiazide 5; 6.25 mg/1; mg/1

    Bisoprolol Fumarate and Hydrochlorothiazide is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GLENMARK PHARMACEUTICALS INC., USA. The primary component is BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE.

    Product Information

    NDC 68462-0879
    Product ID 68462-879_75c16277-3d61-4c27-a853-485aa7669c0e
    Associated GPIs 36992002130320
    GCN Sequence Number 021140
    GCN Sequence Number Description bisoprolol/hydrochlorothiazide TABLET 5-6.25MG ORAL
    HIC3 J7H
    HIC3 Description BETA-BLOCKERS AND THIAZIDE,THIAZIDE-LIKE DIURETICS
    GCN 45062
    HICL Sequence Number 008715
    HICL Sequence Number Description BISOPROLOL FUMARATE/HYDROCHLOROTHIAZIDE
    Brand/Generic Generic
    Proprietary Name Bisoprolol Fumarate and Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Bisoprolol Fumarate and Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 5; 6.25
    Active Ingredient Units mg/1; mg/1
    Substance Name BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
    Labeler Name GLENMARK PHARMACEUTICALS INC., USA
    Pharmaceutical Class Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA215995
    Listing Certified Through 2025-12-31

    Package

    NDC 68462-0879-05 (68462087905)

    NDC Package Code 68462-879-05
    Billing NDC 68462087905
    Package 500 TABLET, FILM COATED in 1 BOTTLE (68462-879-05)
    Marketing Start Date 2022-01-26
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.25443
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis